Strategic Analysis of the Pharmaceutical Sector in Morocco and Quality Approach

The pharmaceutical industry constitutes a link of the Moroccan industrial sector, especially after the adoption of European good manufacturing practices (GMP) as regulatory quality standard. In a context where the economy is globalizing, competition becomes total, technology evolves more and more and the factors which determine competitiveness change. The pharmaceutical industry, being a component of the national economy, is challenged to guarantee the perenniality of its investments and pretend to growth. In the same context, questions arise now, they are the strengths and weaknesses of national pharmaceutical industry What is its threats and exists opportunities which arise In which degree of maturity is it the quality system of national pharmaceutical industry The objective of this article is to provide a photograph of this sector taken in its environment through a strategic analysis. After contextualization, the second part of this article presents the methodology. This work was conducted by the adoption of the combined matrix SWOT at tool PESTEL for the external diagnosis and at the approach by resources for the internal diagnosis. This analysis made it possible to reveal the strengths, weaknesses, opportunities and threats, in times present, of this industry from publications referenced, detailed in the third part of this article. The results of this study show the contribution of this industry to the social balance. And secondly, highlights the handicaps that hinder the development of the latter. Following the discussion, in last part, results obtained migration the quality system of Moroccan pharmaceutical industry to a management system for quality is defined as a strategic lever for this industry.